ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
538 |
171K |
8 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
538
|
171K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
538 |
171K |
26 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
538
|
171K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
538 |
171K |
15 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
538
|
171K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
538 |
171K |
11 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
538
|
171K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
jsonm
|
236 |
88K |
7 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
236
|
88K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
jsonm
|
538 |
171K |
5 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
538
|
171K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
204 |
72K |
8 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
72K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
204 |
72K |
16 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
204
|
72K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
601 |
235K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
601
|
235K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
601 |
235K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
601
|
235K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
601 |
235K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
601
|
235K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
jsonm
|
601 |
235K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
601
|
235K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
jsonm
|
549 |
175K |
12 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
549
|
175K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
17K |
6.6M |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
jsonm
|
273 |
119K |
5 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
273
|
119K
|
5
|
|
ASX - By Stock
|
OIL |
Re:
Good signs ....
|
|
jsonm
|
322 |
114K |
8 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
322
|
114K
|
8
|
|
ASX - By Stock
|
OIL |
Re:
Ann: Optiscan appoints US Clinical & Regulatory Heads
|
|
jsonm
|
3 |
1.8K |
12 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
3
|
1.8K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast stock(rock)-take March 2024
|
|
jsonm
|
273 |
119K |
7 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
273
|
119K
|
7
|
|
ASX - By Stock
|
OIL |
Re:
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
|
|
jsonm
|
17 |
14K |
6 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
17
|
14K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
jsonm
|
272 |
101K |
21 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
272
|
101K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
jsonm
|
512 |
126K |
36 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
512
|
126K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
jsonm
|
512 |
126K |
22 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
512
|
126K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Information For Retail Shareholders
|
|
jsonm
|
541 |
115K |
8 |
09/12/23 |
09/12/23 |
ASX - By Stock
|
541
|
115K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
jsonm
|
274 |
120K |
15 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
274
|
120K
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Follow up to NCCN Guidelines for Breast Cancer ASX Release
|
|
jsonm
|
70 |
25K |
5 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
70
|
25K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
jsonm
|
778 |
281K |
3 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
778
|
281K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
17K |
6.6M |
7 |
10/09/22 |
10/09/22 |
ASX - By Stock
|
17K
|
6.6M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
jsonm
|
778 |
281K |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
778
|
281K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
jsonm
|
1.5K |
503K |
16 |
10/07/22 |
10/07/22 |
ASX - By Stock
|
1.5K
|
503K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast
|
|
jsonm
|
14 |
6.8K |
25 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
14
|
6.8K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
146K |
8 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
146K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
146K |
7 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
146K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
jsonm
|
484 |
146K |
52 |
18/06/22 |
18/06/22 |
ASX - By Stock
|
484
|
146K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
jsonm
|
17K |
6.6M |
1 |
25/05/22 |
25/05/22 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
jsonm
|
150 |
55K |
4 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Crohn’s Disease
|
|
jsonm
|
150 |
55K |
27 |
20/05/22 |
20/05/22 |
ASX - By Stock
|
150
|
55K
|
27
|
|
ASX - By Stock
|
MSB |
The Big Blast
|
|
jsonm
|
0 |
516 |
32 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
0
|
516
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
jsonm
|
190 |
62K |
9 |
30/04/22 |
30/04/22 |
ASX - By Stock
|
190
|
62K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
jsonm
|
317 |
73K |
0 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
317
|
73K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Reality
|
|
jsonm
|
317 |
73K |
1 |
18/04/22 |
18/04/22 |
ASX - By Stock
|
317
|
73K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
jsonm
|
213 |
58K |
1 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
213
|
58K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
jsonm
|
213 |
58K |
21 |
27/03/22 |
27/03/22 |
ASX - By Stock
|
213
|
58K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
jsonm
|
1.0K |
328K |
1 |
25/03/22 |
25/03/22 |
ASX - By Stock
|
1.0K
|
328K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
jsonm
|
505 |
160K |
14 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
505
|
160K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
jsonm
|
4.7K |
1.1M |
4 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
40K |
4 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
151
|
40K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
jsonm
|
1.0K |
328K |
9 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
1.0K
|
328K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
40K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
40K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
40K |
3 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
40K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
jsonm
|
151 |
40K |
2 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
40K
|
2
|
|